Last 12 months
Inside the activity.
0 purchase rows · 169 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 23 |
| Dec 2025 | 0 | 18 |
| Jan 2026 | 0 | 44 |
| Feb 2026 | 0 | 22 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 10 |
| May 2026 | 0 | 19 |
| Jun 2026 | 0 | 13 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 03, 2025 Filed Mar 5, 2025 22:27 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 758 | $77.75 | $58,934.50 |
DisclosureSEC source: 0001628280-25-010590 · wk-form4_1741213663.xml · nonDerivative · entry 3 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 344,861 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 758 shares sold at prices ranging from $77.13 to $78.12 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:27 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 7,317 | $76.24 | $557,848.08 |
DisclosureSEC source: 0001628280-25-010590 · wk-form4_1741213663.xml · nonDerivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 345,619 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 7,317 shares sold at prices ranging from $75.91 to $76.90 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:27 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 18,750 | $22.76 | $426,750.00 |
DisclosureSEC source: 0001628280-25-010590 · wk-form4_1741213663.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 352,936 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 21:39 UTC |
SHAROKY MELVIN MDDirector
|
GiftCommon Stock | 481 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-008715 · wk-form4_1740692375.xml · nonDerivative · entry 4 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Melvin Sharoky C/F Sophie C. Wink UTMA/FL Disclosed balance after: 4,764 F3 · ownership.nature: The Reporting Person is the custodian of Melvin Sharoky C/F Sophie C. Wink UTMA/FL. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 21:39 UTC |
SHAROKY MELVIN MDDirector
|
GiftCommon Stock | 481 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-008715 · wk-form4_1740692375.xml · nonDerivative · entry 3 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Melvin Sharoky C/F Tulia L. Sharoky UTMA/FL Disclosed balance after: 3,481 F2 · ownership.nature: The Reporting Person is the custodian of Melvin Sharoky C/F Tulia L. Sharoky UTMA/FL. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 21:39 UTC |
SHAROKY MELVIN MDDirector
|
GiftCommon Stock | 481 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-008715 · wk-form4_1740692375.xml · nonDerivative · entry 2 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Melvin Sharoky C/F Nolan M. Wink UTMA/FL Disclosed balance after: 5,180 F1 · ownership.nature: The Reporting Person is the custodian of Melvin Sharoky C/F Nolan M. Wink UTMA/FL. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 21:39 UTC |
SHAROKY MELVIN MDDirector
|
GiftCommon Stock | 1,443 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-008715 · wk-form4_1740692375.xml · nonDerivative · entry 1 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 296,734 Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:52 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,830 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001628280-25-006807 · wk-form4_1740088354.xml · derivative · entry 11 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 204,970 Underlying: Common Stock · 6,830 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F9 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:52 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 18,750 | $0.00 Strike: $22.76 | $0.00 |
DisclosureSEC source: 0001628280-25-006807 · wk-form4_1740088354.xml · derivative · entry 10 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 18,750 shares Expires 2025-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F9 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:52 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 300 | $81.81 | $24,543.00 |
DisclosureSEC source: 0001628280-25-006807 · wk-form4_1740088354.xml · nonDerivative · entry 8 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 233,924 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F8 · price: This is the weighted average sales price representing 300 shares sold at prices ranging from $81.69 to $82.01 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:52 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 6,074 | $81.07 | $492,419.18 |
DisclosureSEC source: 0001628280-25-006807 · wk-form4_1740088354.xml · nonDerivative · entry 7 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 234,224 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F7 · price: This is the weighted average sales price representing 6,074 shares sold at prices ranging from $80.51 to $81.42 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:52 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 456 | $80.00 | $36,480.00 |
DisclosureSEC source: 0001628280-25-006807 · wk-form4_1740088354.xml · nonDerivative · entry 6 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 240,298 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6 · price: This is the weighted average sales price representing 456 shares sold at prices ranging from $79.50 to $80.34 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:52 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 6,830 | $10.85 | $74,105.50 |
DisclosureSEC source: 0001628280-25-006807 · wk-form4_1740088354.xml · nonDerivative · entry 5 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 240,754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:52 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 754 | $81.67 | $61,579.18 |
DisclosureSEC source: 0001628280-25-006807 · wk-form4_1740088354.xml · nonDerivative · entry 4 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 334,186 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · price: This is the weighted average sales price representing 754 shares sold at prices ranging from $81.56 to $81.78 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:52 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 16,743 | $81.08 | $1,357,522.44 |
DisclosureSEC source: 0001628280-25-006807 · wk-form4_1740088354.xml · nonDerivative · entry 3 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 334,940 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 16,743 shares sold at prices ranging from $80.50 to $81.43 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:52 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 1,253 | $79.95 | $100,177.35 |
DisclosureSEC source: 0001628280-25-006807 · wk-form4_1740088354.xml · nonDerivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 351,683 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 1,253 shares sold at prices ranging from $79.50 to $80.35 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:52 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 18,750 | $22.76 | $426,750.00 |
DisclosureSEC source: 0001628280-25-006807 · wk-form4_1740088354.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 352,936 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · balance_after: Since the date of the last ownership report for the Reporting Person, he transferred 92,155 shares of Company common stock, employee stock options to purchase 1,064,717 shares of Company common stock, and restricted stock units covering 27,553 shares of Company common stock to his ex-spouse pursuant to a mutually agreed divorce settlement approved by a court that qualifies as a domestic relations order. A domestic relations order is a court order that dictates how assets should be divided between spouses during a divorce, including securities in the Company. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:52 UTC |
Bonstein SaraChief Financial Officer
|
SaleCommon Stock | 700 | $81.00 | $56,700.00 |
DisclosureSEC source: 0001628280-25-006804 · wk-form4_1740088339.xml · nonDerivative · entry 2 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,863 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 700 shares sold at prices ranging from $81.00 to $81.01 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:52 UTC |
Bonstein SaraChief Financial Officer
|
SaleCommon Stock | 17,622 | $80.28 | $1,414,694.16 |
DisclosureSEC source: 0001628280-25-006804 · wk-form4_1740088339.xml · nonDerivative · entry 1 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,563 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 17,622 shares sold at prices ranging from $80.00 to $80.99 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 12, 2025 Filed Feb 13, 2025 22:09 UTC |
Bonstein SaraChief Financial Officer
|
SaleCommon Stock | 5,019 | $80.00 | $401,520.00 |
DisclosureSEC source: 0001628280-25-005465 · wk-form4_1739484553.xml · nonDerivative · entry 2 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 137,185 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 22:09 UTC |
Bonstein SaraChief Financial Officer
|
SaleCommon Stock | 13,302 | $80.00 | $1,064,160.00 |
DisclosureSEC source: 0001628280-25-005465 · wk-form4_1739484553.xml · nonDerivative · entry 1 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,204 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:45 UTC |
Adsett RogerChief Operating Officer
|
SaleCommon Stock | 26,141 | $79.33 | $2,073,765.53 |
DisclosureSEC source: 0001628280-25-005166 · wk-form4_1739396737.xml · nonDerivative · entry 3 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,082 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 26,141 shares sold at prices ranging from $78.61 to $79.54 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:45 UTC |
Adsett RogerChief Operating Officer
|
SaleCommon Stock | 5,781 | $78.36 | $452,999.16 |
DisclosureSEC source: 0001628280-25-005166 · wk-form4_1739396737.xml · nonDerivative · entry 2 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 172,223 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 5,781 shares sold at prices ranging from $78.10 to $78.59 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:45 UTC |
Adsett RogerChief Operating Officer
|
SaleCommon Stock | 11,053 | $77.02 | $851,302.06 |
DisclosureSEC source: 0001628280-25-005166 · wk-form4_1739396737.xml · nonDerivative · entry 1 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 178,004 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 11,053 shares sold at prices ranging from $76.74 to $77.60 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:45 UTC |
Flammer Martina M.D.Chief Medical Officer
|
SaleCommon Stock | 23,010 | $79.33 | $1,825,383.30 |
DisclosureSEC source: 0001628280-25-005165 · wk-form4_1739396726.xml · nonDerivative · entry 3 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100,165 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 23,010 shares sold at prices ranging from $78.61 to $79.54 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:45 UTC |
Flammer Martina M.D.Chief Medical Officer
|
SaleCommon Stock | 5,089 | $78.36 | $398,774.04 |
DisclosureSEC source: 0001628280-25-005165 · wk-form4_1739396726.xml · nonDerivative · entry 2 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 123,175 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 5,089 shares sold at prices ranging from $78.10 to $78.59 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:45 UTC |
Flammer Martina M.D.Chief Medical Officer
|
SaleCommon Stock | 9,729 | $77.02 | $749,327.58 |
DisclosureSEC source: 0001628280-25-005165 · wk-form4_1739396726.xml · nonDerivative · entry 1 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 128,264 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 9,729 shares sold at prices ranging from $76.74 to $77.60 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 07, 2025 Filed Feb 7, 2025 22:11 UTC |
Flammer Martina M.D.Chief Medical Officer
|
SaleCommon Stock | 60 | $79.59 | $4,775.40 |
DisclosureSEC source: 0001628280-25-004465 · wk-form4_1738966304.xml · nonDerivative · entry 3 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,993 F2 · shares: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees. Read SEC document |
| February 07, 2025 Filed Feb 7, 2025 22:11 UTC |
Adsett RogerChief Operating Officer
|
SaleCommon Stock | 100 | $79.57 | $7,957.00 |
DisclosureSEC source: 0001628280-25-004463 · wk-form4_1738966283.xml · nonDerivative · entry 3 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,057 F2 · shares: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees. F4 · price: This is the weighted average sales price representing 100 shares sold at prices ranging from $79.56 to $79.57 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 07, 2025 Filed Feb 7, 2025 22:11 UTC |
Wise John DraytonChief Commercial Officer
|
SaleCommon Stock | 10 | $78.91 | $789.10 |
DisclosureSEC source: 0001628280-25-004460 · wk-form4_1738966262.xml · nonDerivative · entry 3 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,015 F2 · shares: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees. Read SEC document |
| February 06, 2025 Filed Feb 7, 2025 22:11 UTC |
Flammer Martina M.D.Chief Medical Officer
|
SaleCommon Stock | 33,055 | $80.90 | $2,674,149.50 |
DisclosureSEC source: 0001628280-25-004465 · wk-form4_1738966304.xml · nonDerivative · entry 2 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,053 F2 · shares: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees. F3 · price: This is the weighted average sales price representing 33,055 shares sold at prices ranging from $80.57 to $81.43 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 06, 2025 Filed Feb 7, 2025 22:11 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
SaleCommon Stock | 23,500 | $80.90 | $1,901,150.00 |
DisclosureSEC source: 0001628280-25-004464 · wk-form4_1738966294.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,878 F2 · shares: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees. F3 · price: This is the weighted average sales price representing 23,500 shares sold at prices ranging from $80.57 to $81.43 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 06, 2025 Filed Feb 7, 2025 22:11 UTC |
Adsett RogerChief Operating Officer
|
SaleCommon Stock | 45,605 | $80.90 | $3,689,444.50 |
DisclosureSEC source: 0001628280-25-004463 · wk-form4_1738966283.xml · nonDerivative · entry 2 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,157 F2 · shares: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees. F3 · price: This is the weighted average sales price representing 45,605 shares sold at prices ranging from $80.57 to $81.43 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 06, 2025 Filed Feb 7, 2025 22:11 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 79,350 | $80.90 | $6,419,415.00 |
DisclosureSEC source: 0001628280-25-004461 · wk-form4_1738966272.xml · nonDerivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 453,894 F2 · shares: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees. F3 · price: This is the weighted average sales price representing 79,350 shares sold at prices ranging from $80.57 to $81.43 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 06, 2025 Filed Feb 7, 2025 22:11 UTC |
Wise John DraytonChief Commercial Officer
|
SaleCommon Stock | 7,910 | $80.90 | $639,919.00 |
DisclosureSEC source: 0001628280-25-004460 · wk-form4_1738966262.xml · nonDerivative · entry 2 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,025 F2 · shares: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees. F3 · price: This is the weighted average sales price representing 7,910 shares sold at prices ranging from $80.57 to $81.43 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 06, 2025 Filed Feb 7, 2025 22:10 UTC |
Bonstein SaraChief Financial Officer
|
SaleCommon Stock | 28,390 | $80.90 | $2,296,751.00 |
DisclosureSEC source: 0001628280-25-004459 · wk-form4_1738966251.xml · nonDerivative · entry 2 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,506 F2 · shares: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees. F3 · price: This is the weighted average sales price representing 28,390 shares sold at prices ranging from $80.57 to $81.43 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 06, 2025 Filed Feb 7, 2025 22:10 UTC |
Smith Michael AlexanderChief Legal Officer
|
SaleCommon Stock | 20,650 | $80.90 | $1,670,585.00 |
DisclosureSEC source: 0001628280-25-004458 · wk-form4_1738966239.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,610 F2 · shares: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees. F3 · price: This is the weighted average sales price representing 20,650 shares sold at prices ranging from $80.57 to $81.43 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 22:11 UTC |
Flammer Martina M.D.Chief Medical Officer
|
GrantCommon Stock | 70,943 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-004465 · wk-form4_1738966304.xml · nonDerivative · entry 1 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,108 F1 · shares: Represents shares of common stock acquired upon vesting of Performance Stock Units (PSUs) that were originally granted on January 6, 2022, which vested on February 5, 2025 upon the achievement of the applicable performance and service conditions. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 22:11 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
GrantCommon Stock | 47,295 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-004464 · wk-form4_1738966294.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,378 F1 · shares: Represents shares of common stock acquired upon vesting of Performance Stock Units (PSUs) that were originally granted on January 6, 2022, which vested on February 5, 2025 upon the achievement of the applicable performance and service conditions. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 22:11 UTC |
Adsett RogerChief Operating Officer
|
GrantCommon Stock | 88,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-004463 · wk-form4_1738966283.xml · nonDerivative · entry 1 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 234,762 F1 · shares: Represents shares of common stock acquired upon vesting of Performance Stock Units (PSUs) that were originally granted on January 6, 2022, which vested on February 5, 2025 upon the achievement of the applicable performance and service conditions. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 22:11 UTC |
Lewis WilliamDirector · Chair and CEO
|
GrantCommon Stock | 153,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-004461 · wk-form4_1738966272.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 533,244 F1 · shares: Represents shares of common stock acquired upon vesting of Performance Stock Units (PSUs) that were originally granted on January 6, 2022, which vested on February 5, 2025 upon the achievement of the applicable performance and service conditions. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 22:11 UTC |
Wise John DraytonChief Commercial Officer
|
GrantCommon Stock | 15,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-004460 · wk-form4_1738966262.xml · nonDerivative · entry 1 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,935 F1 · shares: Represents shares of common stock acquired upon vesting of Performance Stock Units (PSUs) that were originally granted on January 6, 2022, which vested on February 5, 2025 upon the achievement of the applicable performance and service conditions. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 22:10 UTC |
Bonstein SaraChief Financial Officer
|
GrantCommon Stock | 65,033 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-004459 · wk-form4_1738966251.xml · nonDerivative · entry 1 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,896 F1 · shares: Represents shares of common stock acquired upon vesting of Performance Stock Units (PSUs) that were originally granted on January 6, 2022, which vested on February 5, 2025 upon the achievement of the applicable performance and service conditions. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 22:10 UTC |
Smith Michael AlexanderChief Legal Officer
|
GrantCommon Stock | 47,295 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-004458 · wk-form4_1738966239.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,260 F1 · shares: Represents shares of common stock acquired upon vesting of Performance Stock Units (PSUs) that were originally granted on January 6, 2022, which vested on February 5, 2025 upon the achievement of the applicable performance and service conditions. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:44 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,830 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001628280-25-004076 · wk-form4_1738791860.xml · derivative · entry 13 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 211,800 Underlying: Common Stock · 6,830 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F9 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:44 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 18,750 | $0.00 Strike: $22.76 | $0.00 |
DisclosureSEC source: 0001628280-25-004076 · wk-form4_1738791860.xml · derivative · entry 12 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,250 Underlying: Common Stock · 18,750 shares Expires 2025-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F9 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:44 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 2,581 | $78.40 | $202,350.40 |
DisclosureSEC source: 0001628280-25-004076 · wk-form4_1738791860.xml · nonDerivative · entry 10 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 233,924 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F8 · price: This is the weighted average sales price representing 2,581 shares sold at prices ranging from $78.26 to $78.75 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:44 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 3,463 | $77.95 | $269,940.85 |
DisclosureSEC source: 0001628280-25-004076 · wk-form4_1738791860.xml · nonDerivative · entry 9 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 236,505 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F7 · price: This is the weighted average sales price representing 3,463 shares sold at prices ranging from $77.24 to $78.23 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:44 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 745 | $76.43 | $56,940.35 |
DisclosureSEC source: 0001628280-25-004076 · wk-form4_1738791860.xml · nonDerivative · entry 8 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 239,968 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6 · price: This is the weighted average sales price representing 745 shares sold at prices ranging from $76.10 to $76.90 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:44 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 41 | $74.86 | $3,069.26 |
DisclosureSEC source: 0001628280-25-004076 · wk-form4_1738791860.xml · nonDerivative · entry 7 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 240,713 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.